Search Results 51-60 of 40906 for Two-phase

  1. Hodgkin lymphoma (Hodgkin disease) - Stages - Mayo Clinic

    A stage 2 Hodgkin lymphoma involves two or more lymph node regions on the same side of the diaphragm. Stage 3 lymphoma. At stage 3, Hodgkin lymphoma ...

  2. Study Is To Assess The Safety And Tolerability Of VTx-002 In Participants With ALS - Mayo Clinic

    PIONEER-ALS is a Phase 1/2, multicenter, open-label, ascending dose ... Two escalating dose (low dose and high dose) cohorts are planned. The duration ...

  3. A Phase 2 Trial Of AMI MultiStem® Therapy In Subjects With Non-ST Elevation Acute Myocardial Infarction - Mayo Clinic

    Clinical Trials · A Phase 2 Trial Of AMI MultiStem® Therapy In Subjects With Non-ST Elevation Acute Myocardial Infarction · More about research at Mayo Clinic.

  4. Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL - Mayo Clinic

    TP-0903 is shown to block cancer cell epithelial-to-mesenchymal transitions. AXL was identified as a potential therapeutic target in chronic lymphocytic ...

  5. centers-of-excellence

    Overview Tab Title Description Study type Interventional Study phase 2 Study IDs Study type Interventional Describes the nature of a ...

  6. Clinical trials - Oncology (Medical)

    The study will be performed in two phases: Phase I will be performed for ... Note: Mayo Clinic is only participating in the Phase 2 - Cohort 3 (UPLIFT) portion of ...

  7. Oncology (Medical) - Clinical trials

    The study will be performed in two phases: Phase I will be performed for ... Note: Mayo Clinic is only participating in the Phase 2 - Cohort 3 (UPLIFT) portion of ...

  8. Phase 2 Study to Evaluate Safety and Efficacy of RM-131 Administered to Patients With Chronic Constipation - Mayo Clinic

    Phase 2 Study to Evaluate Safety and Efficacy of RM-131 Administered to Patients With Chronic Constipation · Overview · Participation eligibility · Participating ...

  9. Phase 1/2 Study Of MRTX1719 In Solid Tumors With MTAP Deletion - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. A Randomized, Open-label Two-arm Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy after Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma - Mayo Clinic

    A Randomized, Open-label Two-arm Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy after Rituximab Containing Chemotherapy ...